| Stage | JILL | % of rev | CIX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $155M | 100.00% | $44M | 100.00% | JILL ×3.55 |
| Gross profit | $119M | 76.85% | $16M | 35.62% | JILL +41.2pp |
| Operating income | $24M | 15.68% | $9M | 20.45% | CIX +4.8pp |
| Pre-tax income | $23M | 15.17% | $10M | 21.97% | CIX +6.8pp |
| Net income | $17M | 10.83% | $7M | 16.65% | CIX +5.8pp |
| Stage | JILL | CIX | Gap · A − B |
|---|---|---|---|
| Revenue | $155M100.00% | $44M100.00% | JILL ×3.55 |
| Gross profit | 76.85%$119M | 35.62%$16M | JILL +41.2pp |
| Operating income | 15.68%$24M | 20.45%$9M | CIX +4.8pp |
| Pre-tax income | 15.17%$23M | 21.97%$10M | CIX +6.8pp |
| Net income |
| 10.83%$17M |
| 16.65%$7M |
| CIX +5.8pp |
None
No disclosed counterparties: JILL.